ArticleMolecules (Basel, Switzerland)2023
Polylysine-Containing Hydrogel Formulation of Fuzapladib, Inhibitor of Leukocyte-Function Associated Antigen-1 (LFA-1) Activation, for Sustained Release.
Koji Higuchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.